Exercising too much is just as risky for your heart as too little
Lifestyle factors, not bad luck, play a central role in atrial fibrillation and its treatment. Exercising too much is just as risky for your heart as too little.
Lifestyle factors, not bad luck, play a central role in atrial fibrillation and its treatment. Exercising too much is just as risky for your heart as too little.
Earlier this month I promised to put together teaching points from the Rich Peverley story. His was an interesting case of sudden collapse that likely occurred as a result of atrial fibrillation therapy rather than atrial fibrillation itself. This was my original report: Important lessons from the collapse of NHL player Rich Peverley (BTW: It set […]
Professional hockey player Rich Peverley gave a news conference today in which he and his medical team announced surprising details about his heart condition. We learned that atrial fibrillation and its treatment featured prominently in his collapse during a game earlier this week. “A flare-up last week led Peverley to skip a road game, and […]
Boston Scientific (BSX) announced it has received U.S. Food and Drug Administration approval for its IntellaTip MiFi XP catheter and 501(k) clearance for its Zurpaz 8.5F steerable sheath, growing its EP mapping/ablation technology portfolio. This makes it the third major player–following both St. Jude Medical, which acquired Endosense, and GE, which invested in Acutus Medical–to […]
The growing A-fib market continues to gain the attention of the major players this week: GE Ventures helped Acutus Medical to close a $28 million Series B round. The San Diego-based startup is working to develop a minimally invasive, real-time 3-D Cardiac Chamber Imaging and Dipole Density Mapping system. This technology could help physicians locate […]
As predicted, the next incremental advances in the growing A-fib heart space may very well be in contact force catheter technology. St. Jude’s Medical is banking on it. The company just acquired Endosense, a Switzerland company that creates contact force ablation catheter technology, for $170 million. If Endosense meets an undisclosed regulatory milestone, it could […]
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Years of financial and safety woes in the implantable cardioverter defibrillator market haven’t scared off this early-stage medical device startup. Asclepius Innovative Solutions (AIS Inc. for short) has retained its determination to bring some peace of mind to people with ICDs by making it easier for doctors to keep tabs on how the life-saving devices […]
It’s a good time to enter the EP-mapping and ablation device market, as Millennium Research Group reports, the more and more popular A-fib ablation procedure will drive those areas toward a value of more than $2.4 billion by 2021. The increase in atrial fibrillation ablations will drive strong growth in the electrophysiology (EP)-mapping and the […]
It’s time to do an update on the treatment of atrial fibrillation. It’s been a while, and there are worthy things to report from the real world. Stroke prevention in AF: Always start with basics: The most important aspect of treating atrial fibrillation is preventing stroke. Although there are some innovative devices and procedures in […]